Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
---|---|---|---|---|---|---|---|---|---|---|---|
ZLAB | Zai Lab Ltd | Amado Rafael | See Remarks | Aug 12, 2024 | Sale | $16.20 | 3,115 | 50,463 | 20,417 | Aug 14, 2024, 04:18 PM | |
ZLAB | Zai Lab Ltd | Amado Rafael | See Remarks | Apr 03, 2024 | Option Exercise | $15.90 | 5,391 | 85,717 | 25,484 | Apr 05, 2024, 05:47 PM | |
ZLAB | Zai Lab Ltd | Amado Rafael | See Remarks | Apr 04, 2024 | Sale | $15.67 | 1,952 | 30,594 | 23,532 | Apr 05, 2024, 05:47 PM | |
ZLAB | Zai Lab Ltd | Amado Rafael | See Remarks | Mar 15, 2024 | Sale | $18.86 | 2,544 | 47,980 | 20,093 | Mar 19, 2024, 04:12 PM | |
ZLAB | Zai Lab Ltd | Amado Rafael | See Remarks | Jan 02, 2024 | Sale | $26.30 | 19,363 | 509,169 | 22,637 | Jan 03, 2024, 07:26 PM | |
ALLO | Allogene Therapeutics, Inc. | Amado Rafael | EVP of R&D | Oct 07, 2022 | Option Exercise | $11.83 | 8,464 | 100,099 | 541,946 | Oct 11, 2022, 04:35 PM | |
ALLO | Allogene Therapeutics, Inc. | Amado Rafael | EVP of R&D | Oct 03, 2022 | Option Exercise | $11.06 | 8,968 | 99,201 | 531,290 | Oct 05, 2022, 04:02 PM | |
ALLO | Allogene Therapeutics, Inc. | Amado Rafael | EVP of R&D and CMO | Aug 02, 2022 | Sale | $11.97 | 2,000 | 23,940 | 540,257 | Aug 02, 2022, 05:40 PM | |
ALLO | Allogene Therapeutics, Inc. | Amado Rafael | EVP of R&D and CMO | Jul 05, 2022 | Sale | $11.44 | 2,000 | 22,880 | 542,257 | Jul 06, 2022, 04:16 PM | |
ALLO | Allogene Therapeutics, Inc. | Amado Rafael | EVP of R&D and CMO | Jun 21, 2022 | Sale | $11.18 | 2,000 | 22,360 | 544,257 | Jun 22, 2022, 04:47 PM | |
ALLO | Allogene Therapeutics, Inc. | Amado Rafael | EVP of R&D and CMO | May 19, 2022 | Sale | $7.40 | 11,500 | 85,092 | 546,257 | May 19, 2022, 05:40 PM | |
ALLO | Allogene Therapeutics, Inc. | Amado Rafael | EVP of R&D and CMO | Mar 15, 2022 | Sale | $7.71 | 5,169 | 39,848 | 320,119 | Mar 17, 2022, 05:59 PM | |
ALLO | Allogene Therapeutics, Inc. | Amado Rafael | EVP of R&D and CMO | Oct 01, 2021 | Sale | $24.35 | 11,507 | 280,185 | 323,928 | Oct 04, 2021, 05:55 PM | |
ALLO | Allogene Therapeutics, Inc. | Amado Rafael | EVP of R&D and CMO | Mar 15, 2021 | Sale | $38.05 | 2,798 | 106,471 | 110,035 | Mar 17, 2021, 05:01 PM | |
ALLO | Allogene Therapeutics, Inc. | Amado Rafael | EVP of R&D and CMO | Oct 07, 2020 | Sale | $39.40 | 16,538 | 651,515 | 111,677 | Oct 08, 2020, 05:10 PM | |
ALLO | Allogene Therapeutics, Inc. | Amado Rafael | EVP of R&D and CMO | Oct 01, 2020 | Sale | $36.37 | 9,752 | 354,662 | 128,215 | Oct 02, 2020, 04:40 PM | |
ADAP | Adaptimmune Therapeutics PLC | Amado Rafael | President, R&D | Aug 06, 2019 | Sale | $2.06 | 11,043 | 22,749 | 17,237 | Aug 07, 2019, 09:00 PM | |
ADAP | Adaptimmune Therapeutics PLC | Amado Rafael | President, R & D | Jan 14, 2019 | Sale | $5.37 | 3,028 | 16,259 | 4,974 | Jan 16, 2019, 09:31 PM |